Cell Signaling – Therapy with DNA repair inhibitors in early phase clinical trials

3C), but the manifestation levels did not change by more than 2 fold during the four time points in the 48 hours post blood feeding

October 21, 2021 climat2050

3C), but the manifestation levels did not change by more than 2 fold during the four time points in the 48 hours post blood feeding.

Cell Signaling

Ufd1 enhances the E3 activity of gp78 and accelerates the degradation of HMGCR (17)

September 30, 2021 climat2050

Ufd1 enhances the E3 activity of gp78 and accelerates the degradation of HMGCR (17). mevalonate pathway, promote ubiquitination and degradation of the HMGCR protein (10,C12).

Category: Cell Signaling

﻿3C), but the manifestation levels did not change by more than 2 fold during the four time points in the 48 hours post blood feeding

﻿Ufd1 enhances the E3 activity of gp78 and accelerates the degradation of HMGCR (17)

3C), but the manifestation levels did not change by more than 2 fold during the four time points in the 48 hours post blood feeding

Ufd1 enhances the E3 activity of gp78 and accelerates the degradation of HMGCR (17)